查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404770

体外受精 (IVF) 市场规模、份额和趋势分析报告：按设备、程序类型、最终用途、地区和细分市场预测，2024-2030 年

In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Nondonor, Frozen Nondonor), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

体外受精 (IVF) 市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球体外受精（IVF）市场规模将达到374亿美元，2024年至2030年复合年增长率为5.54%。

市场成长归功于市场参与者的持续努力、生活方式改变导致不孕症发生率的增加以及政府改善报销政策的倡议。不孕症治疗方式的扩展，例如用于不孕症治疗方法的卵细胞质内单一精虫显微注射术（ICSI）预计将对市场成长产生正面影响。

可以防止体外受精（IVF）期间遗传异常转移的基因组测试设施的可用性预计将推动 IVF 市场的发展。由于体外受精（IVF）治疗数量的增加，保险公司正在为体外受精（IVF）治疗提供保险。例如，2023 年 5 月，太平洋蓝十字推出了增强型个人健康保险，这是一项健康和牙科计划，其中包含计划生育福利，包括生育药物、不孕症治疗和收养的保险。透过这项增强，太平洋蓝十字成为加拿大第一家也是唯一一家提供计划生育福利作为个人健康和牙科计划一部分的保险公司。这使我们能够设定与竞争对手相比竞争的价格，并降低体外受精 (IVF) 疗程的成本。随着治疗变得越来越自动化和标准化，体外受精 (IVF) 正在推动市场发展。

总合生育率（TFR）下降是由于社会行为转变等因素所造成的。这些因素包括从农村社会转变为城市社会的转变、首次怀孕年龄的增加、延迟结婚、就业增加和结婚率下降。 2020 年 3 月，美国生殖医学会和加拿大生育与男科学会宣布，由于 COVID-19 ，美国和加拿大暂停了现场生育治疗。然而，由于放鬆了 COVID-19 限制，许多国家已恢復治疗。 2022 年 1 月在《妇产科》杂誌上发表的一项研究报告称，COVID-19 疫苗不会损害体外受精 (IVF) 的结果。预计这将证明疫苗接种者对体外受精（IVF）的普及。

体外受精 (IVF) 市场报告亮点：

  • 以手术类型来看，与其他手术相比，使用冷冻非捐赠程序进行体外受精(IVF) 的週期数不断增加，因此，到2023 年，使用冷冻非捐赠程序进行体外受精(IVF) 的需求将会增加。,使用冷冻非供体程序的体外受精（IVF）占据了市场主导地位。
  • 从最终用途来看，市场成长的推动因素包括对 ART 治疗的需求不断增加、成本效益、专家的可用性、与卵子和精子库的良好关係以及医院感染的可能性极小或没有。不孕不育治疗诊所市场主导了市场2023年，由于其驱动力。
  • 按设备划分，2023年培养液细分市场占据最大的销售份额。这是由于为提高培养基效率而进行的研究活动越来越多，以及政府对卵子和精子冷冻工作者的资助和机构支持不断增加。
  • 由于诊所越来越多地采用延时显微镜等先进技术、负担得起的治疗以及遵守医疗标准，欧洲将在 2023 年占据最大的市场占有率。
  • 由于对不孕症治疗的高需求以及支持 IVF 的政策和倡议的实施，预计亚太地区对体外受精 (IVF) 的需求将会增加。在日本，符合资格的夫妇最多可以申请三个週期的自筹资金，每个週期 1,920 美元。
  • 亚太地区的新兴国家正在致力于法律改革，以促进该地区接受治疗。例如，2020年2月，印度政府核准了一项法案，对提供辅助生殖技术服务的诊所进行监管，包括体外受精（IVF）、人工授精和代理孕母。
  • 2021年6月，法国下议院正式通过一项法律，允许单身女性和女同性恋夫妇获得辅助生殖技术。这项具有里程碑意义的立法标誌着一个重要的里程碑，为这些个人和夫妇提供免费的不孕症治疗，包括体外受精 (IVF)。
  • 2023年6月，印度第二大生育连锁企业Nova IVF Fertility宣布，计划在未来四年内透过有机扩张和收购，将中心数量扩大到100家。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
  • 市场区隔
  • 从使用者观点分析
    • 消费行为分析
    • 市场影响力分析
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTLE分析
    • 定性分析：COVID-19 疾病对体外受精 (IVF) 市场的影响

第四章体外受精 (IVF) 市场：治疗类型分析

  • 2023 年和 2030 年体外受精 (IVF)市场占有率按手术类型分析
  • 细分仪表板
  • 2018年至2030年治疗类型的市场规模、预测与趋势分析
    • 新鲜的非捐赠者
    • 冷冻非捐赠者
    • 新的捐赠者
    • 冷冻供体

第五章体外受精 (IVF) 市场：最终用途分析

  • 2023 年及 2030 年体外受精 (IVF) 最终用途市场占有率分析
  • 细分仪表板
  • 2018-2030 年最终用途市场规模、预测与趋势分析
    • 不孕不育诊所
    • 医院及其他环境

第六章体外受精（IVF）市场：设备分析

  • 2023年及2030年体外受精（IVF）市场占有率分析
  • 细分仪表板
  • 全球体外受精 (IVF) 市场（按设备），2023-2030 年
  • 2018年至2030年设备市场规模、预测、趋势分析
    • 培养基
    • 免洗装置
    • 资本设备

第七章 区域展望

  • 按地区分類的体外受精 (IVF) 市场：主要市场亮点
  • 生育诊所列表
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章竞争分析

  • 公司简介
    • OvaScience, Inc.
    • Vitrolife AB（publ）
    • Emd Serono, Inc.
    • FUJIFILM Irvine Scientific
    • The Cooper Companies, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bayer AG
    • Merck &Co., Inc.
    • Cook Medical LLC（Cook Group）
    • Genea Biomedx
    • Progyny, Inc.
    • Boston IVF
    • Ferring Pharmaceutical BV
  • 公司分类
  • 公司市场分析
  • 策略规划

第 9 章建议/主要市场见解

Product Code: 978-1-68038-823-7

In Vitro Fertilization Market Growth & Trends:

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, with a CAGR of 5.54% from 2024 to 2030, based on a new report by Grand View Research, Inc.The market's growth can be attributed to the continuous efforts of the market players, an increase in the incidence of infertility due to lifestyle changes, and government initiatives to improve reimbursement policies. Expansion of fertility procedures, such as Intracytoplasmic sperm injection (ICSI) for treating infertility, is expected to have a positive impact on market growth.

The availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. For instance, in May 2023, Pacific Blue Cross introduced an enhanced Personal Health Insurance, a health & dental plan, which incorporates family planning benefits, including coverage for fertility drugs, fertility treatments, and adoption. With this enhancement, Pacific Blue Cross became the first and only provider in Canada to offer family planning benefits as part of an individual health & dental plan. This led to competitive pricing and moderated IVF treatment costs. This procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) results from factors, such as behavioral shifts in society. These factors include a shift from rural to urban societies, increased age of the first pregnancy, postponement of marriage, increased employment, and lower marriage rates. In March 2020, in-person fertility treatments in the U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resumed in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics & Gynecology journal in January 2022 reported that COVID-19 vaccines wouldn't harm IVF outcomes. This is expected to prove the uptake of IVF in eligible vaccinated individuals.

In Vitro Fertilization Market Report Highlights:

  • Based on procedure type, the frozen nondonor type segment dominated the market in 2023 owing to the growing demand for the number of IVF cycles with the aid of frozen nondonor procedures increasing as compared to other procedures
  • Based on end-use, the fertility clinics segment dominated the market in 2023 owing to the rise in demand for ART treatments along with cost-effectiveness, availability of specialists, good relations with the egg & sperm banks, and minimal or no chances of hospital-acquired infections to drive the growth of the market
  • Based on instrument, the culture media segment held the largest revenue share in 2023 owing to a rise in the number of research activities being undertaken to improve the efficiency of culture media along with an increase in government funding and organizational support for employees for egg/sperm freezing
  • Europe held the largest market share in 2023 due to the growing adoption of advanced technologies, such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards
  • Asia Pacific is expected to witness increased demand for IVF owing to high demand for fertility treatments and implemented policies & initiatives to support IVF. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
  • The developing countries in the Asia Pacific are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill to regulate clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
  • In June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction. This groundbreaking law marks a significant milestone, allowing these individuals and couples to receive fertility treatments, including IVF, at no cost
  • In June 2023, Nova IVF Fertility, India's second-largest infertility treatment chain, announced that they plan to reach 100 centers in the next four years through organic expansion and acquisitions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Procedure Type
    • 1.1.2. End-use
    • 1.1.3. Instrument
    • 1.1.4. Region
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
    • 1.3.1. Information procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
    • 1.3.6. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Volume Price Analysis
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Procedure Type
    • 2.2.2. End-use
    • 2.2.3. Instrument
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Segmentation
  • 3.3. User Perspective Analysis
    • 3.3.1. Consumer Behavior Analysis
    • 3.3.2. Market Influencer Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Qualitative Analysis: Impact of COVID-19 on IVF Market

Chapter 4. In Vitro Fertilization Market: Procedure Type Analysis

  • 4.1. In Vitro Fertilization by Procedure Type Market Share Analysis, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global In Vitro Fertilization Procedures Market, by Type, 2018 - 2030
  • 4.4. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Procedure Type
    • 4.4.1. Fresh Nondonor
      • 4.4.1.1. Fresh nondonor market, 2018 - 2030 (USD Million)
    • 4.4.2. Frozen Nondonor
      • 4.4.2.1. Frozen nondonor market, 2018 - 2030 (USD Million)
    • 4.4.3. Fresh Donor
      • 4.4.3.1. Fresh donor market, 2018 - 2030 (USD Million)
    • 4.4.4. Frozen Donor
      • 4.4.4.1. Frozen donor market, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Fertilization Market: End-use Analysis

  • 5.1. In Vitro Fertilization End-use Market Share Analysis, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the following End-use
    • 5.3.1. Fertility Clinics
      • 5.3.1.1. Fertility clinics market, 2018 - 2030 (USD Million)
    • 5.3.2. Hospitals and Other Settings
      • 5.3.2.1. Hospitals and other settings market, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Fertilization Market: Instrument Analysis

  • 6.1. In Vitro Fertilization (IVF) Market Share Analysis, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global IVF Market, by Instrument, 2023 to 2030
  • 6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Instrument
    • 6.4.1. Culture Media
      • 6.4.1.1. Culture media market, 2018 - 2030 (USD Million)
    • 6.4.2. Disposable Devices
      • 6.4.2.1. Disposable devices market, 2018 - 2030 (USD Million)
    • 6.4.3. Capital Equipment
      • 6.4.3.1. Capital equipment market, 2018 - 2030 (USD Million)

Chapter 7. Regional Outlook

  • 7.1. IVF Market by Region: Key Marketplace Takeaway
  • 7.2. List of Few Fertility Clinics
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America IVF market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. estimated fertility rate, 2018 - 2030 (%)
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Reimbursement scenario
      • 7.3.2.4. U.S. IVF market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada estimated fertility rate, 2018 - 2030 (%)
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Reimbursement scenario
      • 7.3.3.4. Canada IVF market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe IVF market, 2018 - 2030 (USD Million)
    • 7.4.2. France
      • 7.4.2.1. France estimated fertility rate, 2018 - 2030 (%)
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Reimbursement scenario
      • 7.4.2.4. France IVF market, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Germany estimated fertility rate, 2018 - 2030 (%)
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Reimbursement Scenario
      • 7.4.3.4. Germany IVF market, 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Italy estimated fertility rate, 2018 - 2030 (%)
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Reimbursement scenario
      • 7.4.4.4. Italy IVF market, 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Spain estimated fertility rate, 2018 - 2030 (%)
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Reimbursement scenario
      • 7.4.5.4. Spain IVF market, 2018 - 2030 (USD Million)
    • 7.4.6. UK
      • 7.4.6.1. UK estimated fertility rate, 2018 - 2030 (%)
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Reimbursement scenario
      • 7.4.6.4. UK IVF market, 2018 - 2030 (USD Million)
    • 7.4.7. Belgium
      • 7.4.7.1. Belgium estimated fertility rate, 2018 - 2030 (%)
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Reimbursement scenario
      • 7.4.7.4. Belgium IVF market, 2018 - 2030 (USD Million)
    • 7.4.8. Netherlands
      • 7.4.8.1. Netherlands estimated fertility rate, 2018 - 2030 (%)
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Reimbursement scenario
      • 7.4.8.4. Netherlands IVF market, 2018 - 2030 (USD Million)
    • 7.4.9. Switzerland
      • 7.4.9.1. Switzerland estimated fertility rate, 2018 - 2030 (%)
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Reimbursement scenario
      • 7.4.9.4. Switzerland IVF market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific IVF market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan estimated fertility rate, 2018 - 2030 (%)
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Rembursement scenario
      • 7.5.2.4. Japan IVF market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. China estimated fertility rate, 2018 - 2030 (%)
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Reimbursement scenario
      • 7.5.3.4. China IVF market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. India estimated fertility rate, 2018 - 2030 (%)
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Reimbursement scenario
      • 7.5.4.4. India IVF market, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Australia estimated fertility rate, 2018 - 2030 (%)
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Reimbursement scenario
      • 7.5.5.4. Australia IVF market, 2018 - 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. South Korea estimated fertility rate, 2018 - 2030 (%)
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Reimbursement scenario
      • 7.5.6.4. South Korea IVF market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America IVF market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil estimated fertility rate, 2018 - 2030 (%)
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Reimbursement scenario
      • 7.6.2.4. Brazil IVF market, 2018 - 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico estimated fertility rate, 2018 - 2030 (%)
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Reimbursement scenario
      • 7.6.3.4. Mexico IVF market, 2018 - 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina estimated fertility rate, 2018 - 2030 (%)
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Reimbursement scenario
      • 7.6.4.4. Argentina IVF market, 2018 - 2030 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. MEA IVF market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa estimated fertility rate, 2018 - 2030 (%)
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Reimbursement scenario
      • 7.7.2.4. South Africa IVF market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Reimbursement scenario
      • 7.7.3.4. Saudi Arabia IVF market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE estimated fertility rate, 2018 - 2030 (%)
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Reimbursement scenario
      • 7.7.4.4. UAE IVF market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Company Profiles
    • 8.1.1. OvaScience, Inc.
      • 8.1.1.1. Overview
      • 8.1.1.2. Financial Performance
      • 8.1.1.3. Service Benchmarking
      • 8.1.1.4. Strategic Initiatives
    • 8.1.2. Vitrolife AB (publ)
      • 8.1.2.1. Overview
      • 8.1.2.2. Financial Performance
      • 8.1.2.3. Service Benchmarking
      • 8.1.2.4. Strategic Initiatives
    • 8.1.3. Emd Serono, Inc.
      • 8.1.3.1. Overview
      • 8.1.3.2. Financial Performance
      • 8.1.3.3. Service Benchmarking
      • 8.1.3.4. Strategic Initiatives
    • 8.1.4. FUJIFILM Irvine Scientific
      • 8.1.4.1. Overview
      • 8.1.4.2. Financial Performance
      • 8.1.4.3. Service Benchmarking
      • 8.1.4.4. Strategic Initiatives
    • 8.1.5. The Cooper Companies, Inc.
      • 8.1.5.1. Overview
      • 8.1.5.2. Financial Performance
      • 8.1.5.3. Service Benchmarking
      • 8.1.5.4. Strategic Initiatives
    • 8.1.6. Thermo Fisher Scientific, Inc.
      • 8.1.6.1. Overview
      • 8.1.6.2. Financial Performance
      • 8.1.6.3. Service Benchmarking
      • 8.1.6.4. Strategic Initiatives
    • 8.1.7. Bayer AG
      • 8.1.7.1. Overview
      • 8.1.7.2. Financial Performance
      • 8.1.7.3. Service Benchmarking
      • 8.1.7.4. Strategic Initiatives
    • 8.1.8. Merck & Co., Inc.
      • 8.1.8.1. Overview
      • 8.1.8.2. Financial Performance
      • 8.1.8.3. Service Benchmarking
      • 8.1.8.4. Strategic Initiatives
    • 8.1.9. Cook Medical LLC (Cook Group)
      • 8.1.9.1. Overview
      • 8.1.9.2. Financial Performance
      • 8.1.9.3. Service Benchmarking
      • 8.1.9.4. Strategic Initiatives
    • 8.1.10. Genea Biomedx
      • 8.1.10.1. Overview
      • 8.1.10.2. Financial Performance
      • 8.1.10.3. Service Benchmarking
      • 8.1.10.4. Strategic Initiatives
    • 8.1.11. Progyny, Inc.
      • 8.1.11.1. Overview
      • 8.1.11.2. Financial Performance
      • 8.1.11.3. Service Benchmarking
      • 8.1.11.4. Strategic Initiatives
    • 8.1.12. Boston IVF
      • 8.1.12.1. Overview
      • 8.1.12.2. Financial Performance
      • 8.1.12.3. Service Benchmarking
      • 8.1.12.4. Strategic Initiatives
    • 8.1.13. Ferring Pharmaceutical B.V.
      • 8.1.13.1. Overview
      • 8.1.13.2. Financial Performance
      • 8.1.13.3. Service Benchmarking
      • 8.1.13.4. Strategic Initiatives
  • 8.2. Company Categorization
  • 8.3. Company Market Position Analysis
  • 8.4. Strategy Mapping

Chapter 9. Recommendations/Key Market Insights

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Clinical Trial Analysis
  • Table 4. Comparison Between the Fresh and Frozen Donor Treatment (U.S.)
  • Table 5. Canadian Law On ART
  • Table 6. Status Of Public Funding for IVF in Canada
  • Table 7. Global In-Vitro Fertilization Market, by Region, 2018 - 2030 (USD Million)
  • Table 8. Global In-Vitro Fertilization Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. Global In-Vitro Fertilization Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 10. Global In-Vitro Fertilization Instruments Market, by Region, 2018 - 2030 (USD Million)
  • Table 11. Global In-Vitro Fertilization Instruments Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. North America In Vitro Fertilization, by Country, 2018 - 2030 (USD Million)
  • Table 13. North America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 14. North America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15. North America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. North America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 18. U.S. In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19. U.S. In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 20. Canada In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. Canada In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22. Canada In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Europe In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 24. Europe In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Europe In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26. Europe In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 27. Europe In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. France In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30. France In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Germany In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32. Germany In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33. Germany In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Italy In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 35. Italy In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36. Italy In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 37. Spain In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. Spain In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39. Spain In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. UK In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 41. UK In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42. UK In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 43. Belgium In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Belgium In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45. Belgium In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. Netherlands In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 47. Netherlands In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48. Netherlands In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Switzerland In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 50. Switzerland In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51. Switzerland In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 52. Asia Pacific In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 57. Japan In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. Japan In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59. Japan In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. China In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61. China In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 62. China In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 63. India In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. India In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65. India In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Australia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 67. Australia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 68. Australia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 69. South Korea In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 70. South Korea In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71. South Korea In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 73. Latin America In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74. Latin America In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 75. Latin America In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 76. Latin America In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 77. Brazil In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 78. Brazil In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 79. Brazil In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 80. Mexico In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 81. Mexico In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82. Mexico In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 83. Argentina In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 84. Argentina In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85. Argentina In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 86. MEA In-vitro Fertilization (IVF) Market, by Country, 2018 - 2030 (USD Million)
  • Table 87. MEA In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 88. MEA In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89. MEA In-vitro Fertilization (IVF) Instrument Market, by Country, 2018 - 2030 (USD Million)
  • Table 90. MEA In-vitro Fertilization (IVF) Instrument Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. South Africa In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 92. South Africa In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93. South Africa In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 94. Saudi Arabia In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 95. Saudi Arabia In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 96. Saudi Arabia In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)
  • Table 97. UAE In-vitro Fertilization (IVF) Market, By Type, 2018 - 2030 (USD Million)
  • Table 98. UAE In-vitro Fertilization (IVF) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 99. UAE In-vitro Fertilization (IVF) Instrument Market, By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In vitro fertilization market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment outlook
  • Fig. 11 Segment outlook
  • Fig. 12 Competitive scenario
  • Fig. 13 In Vitro Fertilization (IVF) parent market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market dynamics
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Market restraint relevance analysis (Current & future impact)
  • Fig. 18 In vitro fertilization (IVF) market: Porter's five forces analysis
  • Fig. 19 In vitro fertilization (IVF) market: PESTLE analysis
  • Fig. 20 IVF type market: Segment dashboard
  • Fig. 21 IVF market by type: Market share analysis, 2023 & 2030
  • Fig. 22 Global In Vitro Fertilization (IVF) procedures market, by type, 2018 - 2030 (USD Million)
  • Fig. 23 Fresh nondonor market, 2018 - 2030 (USD Million)
  • Fig. 24 Frozen nondonor market 2018 - 2030 (USD Million)
  • Fig. 25 Fresh donor market 2018 - 2030 (USD Million)
  • Fig. 26 Frozen donor market 2018 - 2030 (USD Million)
  • Fig. 27 IVF End-Use market: Segment dashboard
  • Fig. 28 IVF market by End-Use: Market share analysis, 2023 & 2030
  • Fig. 29 Fertility clinics market, 2018 - 2030 (USD Million)
  • Fig. 30 Hospitals and other settings market 2018 - 2030 (USD Million)
  • Fig. 31 IVF instrument market: Segment dashboard
  • Fig. 32 IVF market by instrument: Market share analysis, 2023 & 2030
  • Fig. 33 Global In Vitro Fertilization (IVF) procedures market, by instrument, 2018 - 2030 (USD Million)
  • Fig. 34 Culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Disposable devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Capital equipment market, 2018 - 2030 (USD Million)
  • Fig. 37 IVF market revenue, by region
  • Fig. 38 Regional key marketplace takeaway
  • Fig. 39 Regional key marketplace takeaway
  • Fig. 40 North America IVF market, 2018 - 2030 (USD Million)
  • Fig. 41 North America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 43 U.S. IVF market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada estimated fertility rate, 2018 - 2030 (%)
  • Fig. 46 Canada IVF market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe IVF market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 50 France estimated fertility rate, 2018 - 2030 (%)
  • Fig. 51 France IVF market, 2018 - 2030 (USD Million)
  • Fig. 52 France IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany estimated fertility rate, 2018 - 2030 (%)
  • Fig. 54 Germany IVF market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy estimated fertility rate, 2018 - 2030 (%)
  • Fig. 57 Italy IVF market, 2018 - 2030 (USD Million)
  • Fig. 58 Italy IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain estimated fertility rate, 2018 - 2030 (%)
  • Fig. 60 Spain IVF market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 62 UK estimated fertility rate, 2018 - 2030 (%)
  • Fig. 63 UK IVF market, 2018 - 2030 (USD Million)
  • Fig. 64 UK IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 65 Belgium estimated fertility rate, 2018 - 2030 (%)
  • Fig. 66 Belgium IVF market, 2018 - 2030 (USD Million)
  • Fig. 67 Belgium IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 68 Netherlands estimated fertility rate, 2018 - 2030 (%)
  • Fig. 69 Netherlands IVF market, 2018 - 2030 (USD Million)
  • Fig. 70 Netherlands IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 71 Switzerland estimated fertility rate, 2018 - 2030 (%)
  • Fig. 72 Switzerland IVF market, 2018 - 2030 (USD Million)
  • Fig. 73 Switzerland IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific IVF market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan estimated fertility rate, 2018 - 2030 (%)
  • Fig. 77 Japan IVF market, 2018 - 2030 (USD Million)
  • Fig. 78 Japan IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 79 China estimated fertility rate, 2018 - 2030 (%)
  • Fig. 80 China IVF market, 2018 - 2030 (USD Million)
  • Fig. 81 China IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 82 India. estimated fertility rate, 2018 - 2030 (%)
  • Fig. 83 India IVF market, 2018 - 2030 (USD Million)
  • Fig. 84 India IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 85 Australia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 86 Australia IVF market, 2018 - 2030 (USD Million)
  • Fig. 87 Australia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea estimated fertility rate, 2018 - 2030 (%)
  • Fig. 89 South Korea IVF market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 91 Latin America IVF market, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil estimated fertility rate, 2018 - 2030 (%)
  • Fig. 94 Brazil IVF market, 2018 - 2030 (USD Million)
  • Fig. 95 Brazil IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 96 Mexico estimated fertility rate, 2018 - 2030 (%)
  • Fig. 97 Mexico IVF market, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina estimated fertility rate, 2018 - 2030 (%)
  • Fig. 100 Argentina IVF market, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 102 MEA IVF market, 2018 - 2030 (USD Million)
  • Fig. 103 MEA IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa estimated fertility rate, 2018 - 2030 (%)
  • Fig. 105 South Africa IVF market, 2018 - 2030 (USD Million)
  • Fig. 106 South Africa IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 107 Saudi Arabia estimated fertility rate, 2018 - 2030 (%)
  • Fig. 108 Saudi Arabia IVF market, 2018 - 2030 (USD Million)
  • Fig. 109 Saudi Arabia IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 110 UAE estimated fertility rate, 2018 - 2030 (%)
  • Fig. 111 UAE IVF market, 2018 - 2030 (USD Million)
  • Fig. 112 UAE IVF instrument market, 2018 - 2030 (USD Million)
  • Fig. 113 Company categorization
  • Fig. 114 Company market position analysis
  • Fig. 115 Strategy mapping